# A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes

> **NCT00681005** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 178 (actual)

## Conditions studied

- GERD

## Interventions

- **DRUG:** rabeprazole
- **DRUG:** pantoprazole

## Key facts

- **NCT ID:** NCT00681005
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2013-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681005, "A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00681005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
